Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 37-45

  Ohta, Kouji ^a,b   Kajiya, Mikihiko ^a,b   Zhu, Tongbo ^a,b   Nishi, Hiromi ^a   Mawardi, Hani ^a,b   Shin, Jane ^a,b   Elbadawi, Leena ^a,c   Kamata, Nobuyuki ^d   Komatsuzawa, Hitoshi ^e   Kawai, Toshihisa ^a,b  

^a FORSYTH INSTITUTE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^d HIROSHIMA UNIVERSITY   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Antimicrobial activity; LL 37; Neuropeptide; Orexin B; Vasoactive intestinal polypeptide

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; OREXIN B; SODIUM CHLORIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS;

ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; BETA-DEFENSINS; CELLS, CULTURED; DRUG SYNERGISM; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 79953298948     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.11.009     Document Type: Article

References (30)

1. Antunes V.R., Brailoiu G.C., Kwok E.H., Scruggs P., Dun N.J. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:1801-1807.
2. Awawdeh L., Lundy F.T., Shaw C., Lamey P.J., Linden G.J., Kennedy J.G. Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in pulp tissue from painful and healthy human teeth. Int. Endod. J. 2002, 35:30-36.
3. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
4. Brogden K.A., Guthmiller J.M., Salzet M., Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat. Immunol. 2005, 6:558-564.
5. Chen X., Niyonsaba F., Ushio H., Okuda D., Nagaoka I., Ikeda S., Okumura K., Ogawa H. Synergistic effect of antibacterial agents human b-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 2005, 40:123-132.
6. de Lecea L., Kilduff T.S., Peyron Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. PNAS 1998, 95:322-327.
7. Dickinson T., Fleetwood-Walker S.M. VIP and PACAP: very important in pain. Trends Pharmacol. Sci. 1999, 20:324-329.
8. Durr U.H., Sudheendra U.S., Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 2006, 1758:1408-1425.
9. Ehrström M., Gustafsson T., Finn A., Kirchgessner A., Grybäck P., Jacobsson H., Hellström P.M., Näslund E. Inhibitory effect of exogenous orexin A on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J. Clin. Endocrinol. Metab. 2005, 90:2370-2377.
10. El Karim I.A., Linden G.J., Orr D.F., Lundy F.T. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J. Neuroimmunol. 2008, 200:11-16.
11. Harder J., Bartels J., Christophers E., Schroder J.M. A peptide antibiotic from human skin. Nature 1997, 387:861.
12. Hansen C.J., Burnell K.K., Brogden K.A. Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms. J. Neuroimmunol. 2006, 177:215-218.
13. Hosokawa I., Hosokawa Y., Komatsuzawa H., Goncalves R.B., Karimbux N., Napimoga M.H., Seki M., Ouhara K., Sugai M., Taubman M.A., Kawai T. Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clin. Exp. Immunol. 2006, 146:218-225.
14. Ichinose M., Watanabe M. Stimulation of phagocytosis in mouse peritoneal macrophages by orexin-A and orexin B. Biomed. Res. 2004, 25:249-254.
15. Ichinose M., Asai M., Sawada M., Sasaki K., Oomura Induction of outward current by orexin B in mouse peritoneal macrophages. FEBS Lett. 1998, 440:51-54.
16. Jonsdottir I.H. Neuropeptides and their interaction with exercise and immune function. Immunol. Cell Biol. 2000, 78:562-570.
17. Kirchgessner A.L. Orexin in the brain in the brain-gut axis. Endocr. Rev. 2002, 23:1-15.
18. Kirchgessner A.L., Liu M.T. Orexin synthesis and response in the gut. Neuron 1999, 24:941-951.
19. Lehrer R.I., Lichtenstein A.K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 1993, 11:105-128.
20. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., Yamazaki K., Sayama K., Taubman M.A., Kurihara H., Hashimoto K., Sugai M. Staphylococcus aureus susceptibility to innate antimicrobial peptides,-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 2003, 71:3730-3739.
21. Mookherjee N., Rehaume L.M., Hancock R.E. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 2007, 11:993-1004.
22. Peschel A., Otto M., Jack R.W., Kalbacher H., Jung G., Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 1999, 274:8405-8410.
23. Oren Z., Lerman J.C., Gudmundsson G.H., Agerberth B., Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 1999, 341:501-513.
24. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
25. Scott M.G., Davidson D.J., Gold M.R., Bowdish D., Hancock R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 2002, 169:3883-3891.
26. Singh P.K., Jia H.P., Wiles K., Hesselberth J., Liu L., Conway B.A., Greenberg E.P., Valore E.V., Welsh M.J., Ganz T., Tack B.F., McCray P.B. Production of beta-defensins by human airway epithelia. Proc. Natl Acad. Sci. USA 1998, 95:14961-14966.
27. Singh P.K., Tack B.F., McCray P.B., Welsh M.J. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:799-805.
28. Tin S., Sakharkar K.R., Lim C.S., Sakharkar M.K. Activity of chitosans in combination with antibiotics in Pseudomonas aeruginosa. Int. J. Biol. Sci. 2009, 5:153-160.
29. Toriya Y., Hashiguchi I., Maeda K. Immunohistochemical examination of the distribution of macrophages and CGRP-immunoreactive nerve fibers in induced rat periapical lesions. Endod. Dent. Traumatol. 1997, 13:6-12.
30. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.